Image

 

Agilent Technologies Inc. (NYSE: A) and Chungnam National University announced new initiatives to further research in glycomics, the study of complex sugars, in order to develop biomarkers and new therapeutic antibodies to combat diseases such as cancer.

 

Read about it here!

Agilent Technologies and Chungnam National University Announce Glycomics Research Initiatives

 

Advertisements

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s